Publication | Closed Access
Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia
84
Citations
22
References
2018
Year
Hematological MalignancyPreclinical EvaluationAcute Myeloid LeukemiaMedicineHematologyMyeloid NeoplasiaMixed-phenotype Acute LeukemiaAnti-cancer AgentPharmacologyRadiation OncologyCancer ResearchDrug DiscoveryHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1